What's new in neurofibromatosis? Proceedings from the 2009 NF conference: New frontiers

Joseph L. Kissil, Jaishri O. Blakeley, Rosalie E. Ferner, Susan M. Huson, Michel Kalamarides, Victor Felix Mautner, Frank McCormick, Helen Morrison, Roger Packer, Vijaya Ramesh, Nancy Ratner, Katherine A Rauen, David A. Stevenson, Kim Hunter-Schaedle, Kathryn North

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children's Tumor Foundation for over 20 years. The 2009NF Conferencewas held in Portland,Oregon fromJune 13 to June 16, 2009 andco-chaired byKathrynNorthfromtheUniversity of Sydney and The Children's Hospital at Westmead, Sydney, Australia; and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts presented as posters; and threeKeynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, andmore recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly theNFConference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflectedin the highlights from the 2009 NF Conference presented here.

Original languageEnglish (US)
Pages (from-to)269-283
Number of pages15
JournalAmerican Journal of Medical Genetics, Part A
Volume152
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

Keywords

  • Bone dysplasia
  • Learning disabilities
  • Neurofibromatosis type 1
  • Neurofibromatosis type 2
  • NF1
  • NF2
  • Ras/MAPK
  • Schwannomatosis
  • Tumor suppressor

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Fingerprint Dive into the research topics of 'What's new in neurofibromatosis? Proceedings from the 2009 NF conference: New frontiers'. Together they form a unique fingerprint.

Cite this